These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
419 related articles for article (PubMed ID: 23707559)
21. miR-708 acts as a tumor suppressor in human glioblastoma cells. Guo P; Lan J; Ge J; Nie Q; Mao Q; Qiu Y Oncol Rep; 2013 Aug; 30(2):870-6. PubMed ID: 23754151 [TBL] [Abstract][Full Text] [Related]
22. Differential expression of miR16 in glioblastoma and glioblastoma stem cells: their correlation with proliferation, differentiation, metastasis and prognosis. Tian R; Wang J; Yan H; Wu J; Xu Q; Zhan X; Gui Z; Ding M; He J Oncogene; 2017 Oct; 36(42):5861-5873. PubMed ID: 28628119 [TBL] [Abstract][Full Text] [Related]
23. Methylation by EZH2 activates STAT3 in glioblastoma. Cancer Discov; 2013 Jul; 3(7):OF21. PubMed ID: 23847365 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of EZH2 reverses chemotherapeutic drug TMZ chemosensitivity in glioblastoma. Fan TY; Wang H; Xiang P; Liu YW; Li HZ; Lei BX; Yu M; Qi ST Int J Clin Exp Pathol; 2014; 7(10):6662-70. PubMed ID: 25400745 [TBL] [Abstract][Full Text] [Related]
25. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2. Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667 [TBL] [Abstract][Full Text] [Related]
26. Autoregulatory feedback loop of EZH2/miR-200c/E2F3 as a driving force for prostate cancer development. Tao T; Liu D; Liu C; Xu B; Chen S; Yin Y; Ang L; Huang Y; Zhang X; Chen M Biochim Biophys Acta; 2014 Sep; 1839(9):858-65. PubMed ID: 25017995 [TBL] [Abstract][Full Text] [Related]
27. EZH2 regulates the malignancy of human glioblastoma cells via modulation of Twist mRNA stability. Zhai X; Li LS; Zhou YD; Ji WY; Chen H; Xiao H; Liang P Eur J Pharmacol; 2021 Aug; 904():174177. PubMed ID: 34015321 [TBL] [Abstract][Full Text] [Related]
28. Targeting strategies on miRNA-21 and PDCD4 for glioblastoma. Wang G; Wang JJ; Tang HM; To SS Arch Biochem Biophys; 2015 Aug; 580():64-74. PubMed ID: 26142886 [TBL] [Abstract][Full Text] [Related]
29. MicroRNA-598 Inhibits Cell Proliferation and Invasion of Glioblastoma by Directly Targeting Metastasis Associated in Colon Cancer-1 (MACC1). Wang N; Zhang Y; Liang H Oncol Res; 2018 Sep; 26(8):1275-1283. PubMed ID: 29444745 [TBL] [Abstract][Full Text] [Related]
30. The miR-92b functions as a potential oncogene by targeting on Smad3 in glioblastomas. Wu ZB; Cai L; Lin SJ; Lu JL; Yao Y; Zhou LF Brain Res; 2013 Sep; 1529():16-25. PubMed ID: 23892108 [TBL] [Abstract][Full Text] [Related]
31. Overexpression of enhancer of zeste human homolog 2 (EZH2) gene in human cytomegalovirus positive glioblastoma multiforme tissues. Ahani N; Shirkoohi R; Rokouei M; Alipour Eskandani M; Nikravesh A Med Oncol; 2014 Nov; 31(11):252. PubMed ID: 25294424 [TBL] [Abstract][Full Text] [Related]
32. Pattern of retinoblastoma pathway inactivation dictates response to CDK4/6 inhibition in GBM. Wiedemeyer WR; Dunn IF; Quayle SN; Zhang J; Chheda MG; Dunn GP; Zhuang L; Rosenbluh J; Chen S; Xiao Y; Shapiro GI; Hahn WC; Chin L Proc Natl Acad Sci U S A; 2010 Jun; 107(25):11501-6. PubMed ID: 20534551 [TBL] [Abstract][Full Text] [Related]
33. PI3 kinase pathway regulated miRNome in glioblastoma: identification of miR-326 as a tumour suppressor miRNA. Nawaz Z; Patil V; Paul Y; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K Mol Cancer; 2016 Nov; 15(1):74. PubMed ID: 27871300 [TBL] [Abstract][Full Text] [Related]
34. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. Silber J; Lim DA; Petritsch C; Persson AI; Maunakea AK; Yu M; Vandenberg SR; Ginzinger DG; James CD; Costello JF; Bergers G; Weiss WA; Alvarez-Buylla A; Hodgson JG BMC Med; 2008 Jun; 6():14. PubMed ID: 18577219 [TBL] [Abstract][Full Text] [Related]
35. MicroRNA-873 (miRNA-873) inhibits glioblastoma tumorigenesis and metastasis by suppressing the expression of IGF2BP1. Wang RJ; Li JW; Bao BH; Wu HC; Du ZH; Su JL; Zhang MH; Liang HQ J Biol Chem; 2015 Apr; 290(14):8938-48. PubMed ID: 25670861 [TBL] [Abstract][Full Text] [Related]
36. CDK4, CDK6, cyclin D1, p16(INK4a) and EGFR expression in glioblastoma with a primitive neuronal component. Xu G; Li JY J Neurooncol; 2018 Feb; 136(3):445-452. PubMed ID: 29150788 [TBL] [Abstract][Full Text] [Related]
37. Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells. Kim E; Kim M; Woo DH; Shin Y; Shin J; Chang N; Oh YT; Kim H; Rheey J; Nakano I; Lee C; Joo KM; Rich JN; Nam DH; Lee J Cancer Cell; 2013 Jun; 23(6):839-52. PubMed ID: 23684459 [TBL] [Abstract][Full Text] [Related]
38. Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients. Qiu S; Lin S; Hu D; Feng Y; Tan Y; Peng Y J Transl Med; 2013 Jan; 11():10. PubMed ID: 23302469 [TBL] [Abstract][Full Text] [Related]
39. A highly potent CDK4/6 inhibitor was rationally designed to overcome blood brain barrier in gliobastoma therapy. Yin L; Li H; Liu W; Yao Z; Cheng Z; Zhang H; Zou H Eur J Med Chem; 2018 Jan; 144():1-28. PubMed ID: 29247857 [TBL] [Abstract][Full Text] [Related]
40. Differential expression of PDGFRB and EGFR in microvascular proliferation in glioblastoma. Xu G; Li JY Tumour Biol; 2016 Aug; 37(8):10577-86. PubMed ID: 26857280 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]